oxcarbazepine

Generic: oxcarbazepine

Labeler: glenmark pharmaceuticals inc., usa
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name oxcarbazepine
Generic Name oxcarbazepine
Labeler glenmark pharmaceuticals inc., usa
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

oxcarbazepine 150 mg/1

Manufacturer
Glenmark Pharmaceuticals Inc., USA

Identifiers & Regulatory

Product NDC 68462-137
Product ID 68462-137_80b48b96-6521-491c-831a-2356c22e39f1
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA077802
Listing Expiration 2026-12-31
Marketing Start 2007-10-09

Pharmacologic Class

Established (EPC)
anti-epileptic agent [epc]
Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68462137
Hyphenated Format 68462-137

Supplemental Identifiers

RxCUI
312136 312137 312138
UPC
0368462139011 0368462137017 0368462138014
UNII
VZI5B1W380
NUI
N0000175753 N0000008486

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name oxcarbazepine (source: ndc)
Generic Name oxcarbazepine (source: ndc)
Application Number ANDA077802 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 100 TABLET, FILM COATED in 1 BOTTLE (68462-137-01)
  • 500 TABLET, FILM COATED in 1 BOTTLE (68462-137-05)
source: ndc

Packages (2)

Ingredients (1)

oxcarbazepine (150 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "80b48b96-6521-491c-831a-2356c22e39f1", "openfda": {"nui": ["N0000175753", "N0000008486"], "upc": ["0368462139011", "0368462137017", "0368462138014"], "unii": ["VZI5B1W380"], "rxcui": ["312136", "312137", "312138"], "spl_set_id": ["1c713b59-a628-42e6-b166-ae71c3913284"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED in 1 BOTTLE (68462-137-01)", "package_ndc": "68462-137-01", "marketing_start_date": "20071009"}, {"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (68462-137-05)", "package_ndc": "68462-137-05", "marketing_start_date": "20071009"}], "brand_name": "Oxcarbazepine", "product_id": "68462-137_80b48b96-6521-491c-831a-2356c22e39f1", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "68462-137", "generic_name": "Oxcarbazepine", "labeler_name": "Glenmark Pharmaceuticals Inc., USA", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Oxcarbazepine", "active_ingredients": [{"name": "OXCARBAZEPINE", "strength": "150 mg/1"}], "application_number": "ANDA077802", "marketing_category": "ANDA", "marketing_start_date": "20071009", "listing_expiration_date": "20261231"}